IF: 0.587
Cite Score:
0.7
THOMSON REUTERS - SCOPUS

Novel Mutation in the ATP-Binding Cassette Transporter A3 (ABCA3) Encoding Gene Causes Respiratory Distress Syndrome in A Term Newborn in Southwest Iran

AUTHORS

Farideh Rezaei 1 , Mohammad Shafiei 1 , Gholamreza Shariati 2 , 3 , Ali Dehdashtian 3 , Maryam Mohebbi 2 , 3 , * , Hamid Galehdari 1

AUTHORS INFORMATION

1 Deptartment of Genetics, Faculty of Science, Shahid Chamran University, Ahvaz, IR Iran

2 Narges Medical Genetic Laboratory, Ahvaz, IR Iran

3 Jundishapur University of Medical Sciences, Ahvaz, IR Iran

How to Cite: Rezaei F, Shafiei M, Shariati G, Dehdashtian A, Mohebbi M, et al. Novel Mutation in the ATP-Binding Cassette Transporter A3 (ABCA3) Encoding Gene Causes Respiratory Distress Syndrome in A Term Newborn in Southwest Iran, Iran J Pediatr. 2016 ; 26(2):e2493. doi: 10.5812/ijp.2493.

ARTICLE INFORMATION

Iranian Journal of Pediatrics: 26 (2); e2493
Published Online: March 5, 2016
Article Type: Case Report
Received: May 25, 2015
Revised: November 1, 2015
Accepted: November 14, 2015
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

Introduction: ABCA3 glycoprotein belongs to the ATP-binding cassette (ABC) superfamily of transporters, which utilize the energy derived from hydrolysis of ATP for the translocation of a wide variety of substrates across the plasma membrane. Mutations in the ABCA3 gene are knowingly causative for fatal surfactant deficiency, particularly respiratory distress syndrome (RDS) in term babies.

Case Presentation: In this study, Sanger sequencing of the whole ABCA3 gene (NCBI NM_001089) was performed in a neonatal boy with severe RDS. A homozygous mutation has been identified in the patient. Parents were heterozygous for the same missense mutation GGA > AGA at position 202 in exon 6 of the ABCA3 gene (c.604G > A; p.G202R). Furthermore, 70 normal individuals have been analyzed for the mentioned change with negative results.

Conclusions: Regarding Human Genome Mutation Database (HGMD) and other literature recherche, the detected change is a novel mutation and has not been reported before. Bioinformatics mutation predicting tools prefer it as pathogenic.

Keywords

Surfactant ABCA3 Gene Mutation Respiratory Distress Syndrome (RDS) Southwest Iran

Copyright © 2016, Growth & Development Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

1. Introduction

ABCA3 glycoprotein belongs to the ATP-binding cassette (ABC) superfamily of transporters which can be found in all organisms from smallest prokaryotes to human. These proteins utilize the energy derived from hydrolysis of ATP for the translocation of a wide variety of substrates across the plasma membrane, and also across intracellular membranes against a concentration gradient (1, 2). The superfamily is classified in seven distinct subfamilies of transporters ABCA to ABCG, which in turn is divided in multiple subgroups (3, 4).

One of these subfamilies is encoded by the ABCA3 gene located on the short arm of the chromosome 16 (16p13.3) that approximately extends to 80 kbp of the genomic DNA, and consists of 32 exons encoding a polypeptide chain of 1704 amino acids (5). The cDNA of the ABCA3 gene was originally isolated from human modularly thyroid carcinoma cell line in 1996 (6).

ABCA3 protein has been detected in the limiting membrane of lamellar bodies, organelles for assembly, storage and secretion of pulmonary surfactant in alveolar type II cells. It is considered that ABCA3 protein translocates lipids into lamellar bodies (7). The ABCA3 protein also is necessary for the correct formation of functionally lamellar bodies, surfactant homeostasis and exact function of lungs (1).

The surfactant consists of two parts: lipids (90%) and proteins (10%) (8). Surfactant lipids consist of approximately 70% phosphatidylcholine particularly as dipalmitoylphosphatidyl-choline, phosphatidylglycerol (10%), and other lipids at lower levels including phosphatidylethanolamine, phosphatidylinositol etc. (9).

The lipid-rich monolayer structure of pulmonary surfactant is special in that it coats the lumen of alveoli and greatly decreases superficial tension of the alveolar air-liquid interface thus providing mechanical stability and keeping alveolae from atelectasis and collapse at low lung volume (7).

In this study we report a novel mutation that has been discovered in whole exon sequencing of the ABCA3 gene in a family with respiratory distress syndrome in southwest Iran.

2. Case Presentation

The index patient was a 2.8 kg full-term male infant born after an uncomplicated pregnancy at 38 weeks gestational age, via a vaginal delivery, to healthy and consanguineous parents (first cousin couple). His symptoms demonstrated atelectasis, abnormal lung findings and strenuous respiration. There was no family history of lung disease, abortion, mental retardation. He developed severe respiratory distress syndrome.

The patient was urgently hospitalized, ventilation and other routine cares were applied, but unfortunately he was resistant to treatments and died in early days of life.

2.1. Genetic Analysis

Genomic DNA was prepared from blood leukocytes (10 mL) of the proband, his parents and 70 matched unrelated controls (from related ethnicity) without any respiratory distress syndrome by routine salting out protocol.

The 30 coding regions (exons 3 - 32) of the ABCA3 gene (NCBI NM_001089) and the intron-exon boundaries were amplified by PCR with designed primer pairs using Primer3 software (Table 1) (http://primer3.ut.ee/).

Polymerase chain reaction contained: 100 ng genomic DNA, 12.5 µL Master Mix (Amplicon Co.), 25 pmol of each primer and the total of PCR volume was 25 µL. the PCR was done in 35 cycles: 93°C for 1 minute, 63°C for 30 s and 72°C for 30 s and finally the productions of PCR put in the temperature 72°C for 5minutes to complete extension. PCR products were subsequently sequenced using same primers as mentioned in Table 1 and Big Dye Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems 3500 DNA Analyzer). Finally, chromatograms were read and analyzed with by Chromas and DNA Baser v4 software.

Table 1. Primers Used for the Amplification of the ABCA3 Gene
PrimerSequence
abca3-E3-FCTCTGCGTGTTTCTATTGCG
abca3-E3-RAGACAGCCCTTCCCTCAAG
abca3-E4-FCTTGAGGGAAGGGCTGTCT
abca3-E4-RCGTGGAGGCACCACTAGG
abca3-E5-FCCTGAACCACGCAGATTTTT
abca3-E5-RCTGATGGGCTGTGACTGCT
abca3-E6-FCCTCTGTCTGGATCTCTCGG
abca3-E6-RTGTCACTAGTCAACAGCCCG
abca3-E7-FCAAGCATCTCTTCCCCCAT
abca3-E7-RGCGGTTTCTAGAGTGTTGGG
abca3-E8-FGGACAGTCGGACTCAGGC
abca3-E8-RCTCTCCCCGTCCTCACCA
abca3-E9-FAGTCCTCCTGGTCCACCTCT
abca3-E9-RCAGCCTCTGGGTTATTTCCA
abca3-E10-FCCCTTTTGAGGGCACTGAC
abca3-E10-RTGATTCGGAAAGAACAGGCT
abca3-E11-FACACGTGTGCCATCAGGG
abca3-E11-RACCTCTGCACTCAGAGAGGC
abca3-E12-FGTTGCTTTGCTCGTCACAAA
abca3-E12-RACTGCCGTGCTGGTAAGTCT
abca3-E13-FGAGCAGGAGAGGCCTTGG
abca3-E13-RTGAGATGGTGTTAAAGGGGG
abca3-E14-FGGATCTTCATGCTGAATGTGG
abca3-E14-RCTCGAGCACATCAGTGGAAA
abca3-E15-FTTCCTCTCACCAGAACCTCG
abca3-E15-RGTCGAGCAGGAGGGGAAC
abca3-E16-FGTGTGGCTCTACCAGCGTC
abca3-E16-RAAGGTAGCAGCCATTCCCTC
abca3-E17-FGGGATCAGCCAAAGATCTCA
abca3-E17-RGGGATCCCATCTTGGATGTA
abca3-E18-FGGGGGTGATGCTTTAGGAAC
abca3-E18-RGAGCCCAGTCCTAGGTGGA
abca3-E19-FACCATAGTCCCTCCCTCCAC
abca3-E19-RGGGCTTACATGAGGCGTTT
abca3-E20-FCGTCACACAGAACAGCACCT
abca3-E20-RCCTCCCTCAGTACATTCGGA
abca3-E21-FTGATTAGCCATGCTCAGGTG
abca3-E21-RGTCAGTCCTGGGGGCTCT
abca3-E22-FATAACCGAGAACCCGACCTC
abca3-E22-RGTCTGCAGGGGAACGGAT
abca3-E23-FGTGAGCTCCTCTCAGCTTGG
abca3-E23-RCTGGTGCCTCCCTGTCTG
abca3-E24-FGTCCTGGAGGTGGGTGTG
abca3-E24-RGCAGTGACCACGTCCTGAG
abca3-E25-FGAACCTGGAAGGGGAGGAG
abca3-E25-RAGAGACGTGGGGAGCATCT
abca3-E26-FCCAGACCTCCCACATCCAC
abca3-E26-RGTAGTCAGCTGGCAGGAAGG
abca3-E27-FGAGGCTCAGACTGCTCTGCT
abca3-E27-RCCTGTCTCACCCCTTCAGAG
abca3-E28-FGTGGTCCTCTGGAGGAAGG
abca3-E28-RTGCTATGGGGACCTTGATTC
abca3-E29-FACTCTCAGCCTTATTCCCCC
abca3-E29-RACCAGATGCTGATGGGTCTC
abca3-E30-FCTTCCTGTCTGCACAAGCCT
abca3-E30-RGGAGAGGCCTAGGTAGGGG
abca3-E31-FCAAGTCCCATCTCCCCAAT
abca3-E31-RTCACCACAGAGGGAGAGACC
abca3-E32-FCTATTGCCAGAGGACTCCCA
abca3-E32-RGATCTGCATGGTCCATTCCT

Sequence analysis of entire coding exons and the flanking intronic regions of the ABCA3 gene from affected infant revealed a homozygous missense mutation GGA→AGA substitution at exon 6, which causes an amino acid exchange of glycine to argenine at codon 202 (p.Gly202Arg/G202R). In this way, his healthy parents were heterozygous for the same missense mutation, while sequence analysis of exon 6 of healthy control Individuals demonstrated no change at this position (Figure 1).

Figure 1. Sequence Analysis of Entire Coding Exons and the Flanking Intronic Regions of the ABCA3 Gene
Sequence Analysis of Entire Coding Exons and the Flanking Intronic Regions of the ABCA3 Gene

A, Sequencing results show a homozygous GGA > AGA missense in the case of patient; B, a heterozygous GGA > AGA change in his parents; C, control healthy samples were entirely homozygous for wild type allele.

3. Discussion

ABCA3 is a member of ABCA subfamily that has a role in transport of lipids and it is most likely that ABCA3 has same work. The ABCA3 gene is larger than other proteins genes involved in surfactant. Nevertheless, it is reasonable that more mutations event in ABCA3 gene, also because the maximum amount of pulmonary surfactant consists of lipids which in turn are transported by ABCA3 proteins. In this view, ABCA3 gene mutations appear to be the most essential cause of surfactant metabolism and respiratory diseases in newborns.

RDS is a multi-factorial disease with a variety range of clinical symptoms, often occurs in preterm infants and ABCA3 gene mutations are considered as an important factor causing heredity RDS. Otherwise, neonatal RDS is major cause of morbidity for prematurely born infants. Some of ABCA3 gene mutations cause fatal respiratory distress syndrome of newborns while others of moderate mutations result in chronic interstitial lung disease. The most reported types of mutations with clinical significance are missense, deletions, splicing and insertion mutations (Table 2).

Table 2. Types of Currently Reported ABCA3 Gene Mutations (http://www.hgmd.cf.ac.uk/)
Mutation TypeNumber of Mutations
Missense/nonsense56
Splicing8
Regulatory0
Small deletions12
Small insertions5
Small indels1
Gross deletions0
Gross insertions/duplications 0
Complex rearrangements0
Repeat variations0
Total82

Interestingly, the risk of affected RDS is much more in male than in female neonates. To date, there is no rapid and true test for detecting ABCA3 deficiency; indeed some of children with ABCA3 mutations have undergone lung transplantation for their respiratory failure. Other treatment options for mild cases are ventilation, oxygenation and surfactant replacement.

ABCA3 gene analysis revealed one unreported homozygous mutation in the patient, but both parents were heterozygous (carrier) with normal lung function.

In this case, it is likely the missense mutation G202R (Gly202Arg substitution) in exon 6 caused dysfunction of the ABCA3 protein, changing the polarity of amino acid chain, which surely must affect the functionality. This mutation has never been reported in either public data base of single nucleotide polymorphisms (http://www.ncbi.nlm.nih.gov/SNP/), and is located in the first extracellular loop, which intervenes in extracellular interactions that probably have severe effect on protein function.

To confirm the pathogenicity of the detected missense mutation, 70 unrelated healthy (without any clinical signs of lung disease) were searched for the mentioned change.

We used the sorting intolerant from tolerant (SIFT), polymorphism phenotyping 2 (Polyphen 2), predict SNP and mutation taster (www.mutationtaster.org) software to predict pathogenicity of detected mutation and its impact on ABCA3 function. All the mentioned programs predicted G202R as damaging. The clinical phenotype, genetic findings and computational analysis support its deleterious nature. However, our finding would expand the mutation database of the ABCA3 gene and might be useful for further individual screening, at least in Iran.

Acknowledgements

References

  • 1. Weichert N, Kaltenborn E, Hector A, Woischnik M, Schams A, Holzinger A, et al. Some ABCA3 mutations elevate ER stress and initiate apoptosis of lung epithelial cells. Respir Res. 2011; 12 : 4 [DOI][PubMed]
  • 2. Piehler AP, Ozcurumez M, Kaminski WE. A-Subclass ATP-Binding Cassette Proteins in Brain Lipid Homeostasis and Neurodegeneration. Front Psychiatry. 2012; 3 : 17 [DOI][PubMed]
  • 3. van der Deen M, de Vries EG, Timens W, Scheper RJ, Timmer-Bosscha H, Postma DS. ATP-binding cassette (ABC) transporters in normal and pathological lung. Respir Res. 2005; 6 : 59 [DOI][PubMed]
  • 4. Kim WS, Weickert CS, Garner B. Role of ATP-binding cassette transporters in brain lipid transport and neurological disease. J Neurochem. 2008; 104(5) : 1145 -66 [DOI][PubMed]
  • 5. Panigrahy N, Poddutoor PK, Chirla DK. ATP-binding cassette transporter A3 (ABCA3) mutation in a late preterm with respiratory distress syndrome. Indian Pediatr. 2014; 51(7) : 579 -80 [PubMed]
  • 6. Klugbauer N, Hofmann F. Primary structure of a novel ABC transporter with a chromosomal localization on the band encoding the multidrug resistance-associated protein. FEBS Letters. 1996; 391(1) : 61 -5 [DOI]
  • 7. Bullard JE, Nogee LM. Heterozygosity for ABCA3 mutations modifies the severity of lung disease associated with a surfactant protein C gene (SFTPC) mutation. Pediatr Res. 2007; 62(2) : 176 -9 [DOI][PubMed]
  • 8. Nagata K, Yamamoto A, Ban N, Tanaka AR, Matsuo M, Kioka N, et al. Human ABCA3, a product of a responsible gene for abca3 for fatal surfactant deficiency in newborns, exhibits unique ATP hydrolysis activity and generates intracellular multilamellar vesicles. Biochem Biophys Res Commun. 2004; 324(1) : 262 -8 [DOI][PubMed]
  • 9. Lyra PP, Diniz EM. The importance of surfactant on the development of neonatal pulmonary diseases. Clinics (Sao Paulo). 2007; 62(2) : 181 -90 [PubMed]
  • COMMENTS

    LEAVE A COMMENT HERE: